CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Acquisition or sale completed
- 4 Gift Chairman and CEO gave 40,000 shares (gift)
- 8-K Event Other events
- 4 Open-market sale Director sold 1,000 shares at $4.79 ($4,790)
- 4 Shares withheld for taxes VP and Chief Compliance Office gave up 2,149 shares (to pay taxes)
- 4 Shares withheld for taxes Sr VP/Chief Commercial Officer gave up 472 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and Chief Development Off. gave up 3,710 shares (to pay taxes)
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 1,714 shares at an average $5.56 ($9,526)
- 4 Open-market buy Director bought 1,338 shares at an average $5.65 ($7,555)
- 4 Open-market buy Chairman and CEO bought 1,174 shares at an average $5.65 ($6,639)
- 4 Open-market buy Director bought 1,174 shares at an average $5.65 ($6,639)
Page 23 of 52 · 1,039 filings